Purpose: To assess the accuracy of using diagnostic codes from administrative data to infer treatment indications for antidepressants prescribed in primary care. 
| INTRODUCTION
Nearly half of all antidepressants in primary care are prescribed for indications other than depression, including anxiety disorders, insomnia, and pain, among others. 1 When antidepressants are not prescribed for depression, 2 out of 3 prescriptions are for unapproved (off-label) indications where in most cases, the drug's use is not supported by strong evidence. 2 These findings highlight the need for more pharmacovigilance and post-market evaluations on antidepressant use for indications other than depression.
Employment of information from large administrative databases to evaluate antidepressant use is advantageous because such databases can identify large, population-based cohorts of antidepressant users, capture many different off-label uses, and detect rare outcomes or long-term effects that otherwise might not be observed in clinical trials. 3 However, administrative databases do not contain information on treatment indications for drugs, which presents a major obstacle for using these data to evaluate antidepressant use for different indications.
In the absence of documented treatment indications, several stud- 
| METHODS

| Context
This study took place in the Canadian province of Quebec, where all residents are publicly insured for the cost of essential medical care. Over 90% of physicians are reimbursed on a fee-for-service basis, with physicians submitting claims to the provincial health insurance agency (the Régie de l'assurance maladie du Québec [RAMQ]) for services provided in hospitals or private clinics. 9 For each claim, physicians can optionally provide a single diagnostic code using the International Classification of Diseases, Ninth Revision (ICD-9), coding system that represents the main reason for the visit. 10 Quebec also maintains a hospitalization discharge summary database (MED-ECHO) containing details of all hospitalizations at acute care institutions in Quebec. Each discharge summary contains a principal diagnosis and up to 15 secondary diagnoses 9 (up to 25 secondary diagnoses starting in April 2006) recorded by using the ICD-9 system until April 2006 and the ICD-10 system thereafter.
| Study design
We considered 13 plausible conditions where antidepressants would be used, including various on-label 11 and reported off-label indications [12] [13] [14] [15] for antidepressants. We conducted a separate validation study for each indication, where the unit of analysis was the prescription.
| Data sources and inclusion criteria
The Medical Office of the XXIst Century (MOXXI) is an indication-based electronic prescribing and drug management system used by consenting primary care physicians at community-based clinics around 2 major urban centers in Quebec. 16 The MOXXI electronic prescribing tool requires physicians to document at least 1 treatment indication per prescription using either a drop-down menu containing on-label and off- 
KEY POINTS
• Diagnostic codes from administrative health data are often used to infer treatment indications for antidepressant use, but this approach has never been validated against a gold-standard.
• We found that diagnostic codes in administrative health data had poor accuracy for inferring antidepressant treatment indications when compared with treatment indications documented by primary care physicians at the time of prescribing.
• The findings from this study suggest that use of administrative diagnostic codes to infer antidepressant treatment indications could introduce significant misclassification bias in studies where this approach is used.
multiple indications documented, the prescription was classified as reference positive for all the indications. Based on physician-documented treatment indications recorded for antidepressant prescriptions in the MOXXI system. About 1.2% of antidepressant prescriptions were classified as reference positive for multiple treatment indications because more than 1 indication was recorded for the prescription in the MOXXI system.
Quebec health administrative databases
b Based on diagnostic codes in physician billing and hospitalization discharge summary data that were recorded for patients within ±3 days of the prescription date. About 0.6% of antidepressant prescriptions were classified as test positive for multiple treatment indication because diagnostic codes for more than one treatment indication were recorded.
| Patient characteristics
We determined patients' age and sex by using beneficiary information from RAMQ. We measured patients' level of chronic comorbidity by counting the number of distinct Charlson conditions for which the patient had a corresponding diagnostic code 19 recorded in administrative data over the past 365 days.
| Statistical analysis
For each indication, we conducted a separate validation study to calculate 6 measures of accuracy: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative likelihood ratio (LR−) ( and 97.5th percentiles of the distribution of the respective estimates across 1000 bootstrap resamples of the study dataset. 
| Subgroup analyses
| Sensitivity analyses
We conducted sensitivity analyses to investigate the effect of (a) increasing the lookback window for diagnostic codes (−30, −60, −90, −180, and −365 days) and (b) restricting the source of diagnostic codes to hospital data only, claims data only, or claims from the prescriber only (within a lookback window of 365 days).
To investigate how much of the total variance around each accuracy estimate was due to between-physician differences in coding practices, the 95% CIs corrected for both within-patient and withinphysician clustering were compared with 95% CIs corrected for within-patient clustering only. All analyses were conducted by using SAS software, version 9.4.
| RESULTS
The analysis included a total of 77 700 antidepressant prescriptions written by 164 physicians for 17 606 patients. There were equal numbers of male (n = 82, 50.0%) and female (n = 82, 50%) prescribers; most physicians (n = 150, 91.5%) had received their medical training in Canada or the United States, and 76.6% of physicians (n = 126) had been practicing for at least 15 years. Two thirds of patients were female (n = 11 892, 67.7%), and over the study period, each patient According to the MOXXI indications (reference standard), antidepressants were most commonly prescribed for depression (56.3%), anxiety/stress disorders (22.8%), sleeping disorders (10.0%), and pain (5.7%) ( Table 2 ). In comparison, the proportion of antidepressant prescriptions where the patient had diagnostic codes for these indications ("test positive") was considerably lower, especially for depression and sleeping disorders (Table 2) . Consequently, the sensitivity of administrative diagnostic codes was very poor for all treatment indications, ranging from a high of only 31.2% (95% CI, 26.8%-35.9%) for anxiety/stress disorders to as low as 1.3% (95% CI, 0.0%-5.2%) for sexual dysfunction (Table 3) . However, the specificity of diagnostic codes was excellent (90%+) for all treatment indications ( Table 3 ).
The predictive value of having an administrative diagnostic code for a given indication recorded varied between indications. When a diagnostic code for a given indication was recorded, the probability that the antidepressant was truly prescribed for the corresponding indication (ie, according to MOXXI) was high for depression (PPV of 80.3%; 95% CI, 73.7%-85.3%), moderate for obsessive-compulsive disorder (OCD) (69.1%; 95% CI, 51.7%-83.3%), and low (~50% or less) for the remaining indications ( Table 3 ). The high PPV of depression codes was mostly Similarly, conclusions about the predictive value of not having a diagnostic code recorded for a given indication differed depending on whether the NPV or LR− was used as the performance statistic. When a diagnostic code for a given indication was not recorded, the probability that the antidepressant was not prescribed for the corresponding indication in MOXXI was low for depression (NPV of 49.2%; 95% CI, 45.3%-53.2%) but fairly high for anxiety/stress disorders (81.6%; 95% CI, 78.8%-84.0%) and high for sleeping disorders (90.4%; 95% CI, 88.2%-92.4%). For the remaining indications, the NPV was very high (>95%) because of the low prevalence of these indications (Table 3 ). In contrast, the LR− estimates were close to 1.0 for all indications, suggesting that the absence of a diagnostic code for any plausible indication did not improve the ability to rule out the corresponding indication.
| Subgroup analyses
For all indications, there was considerable heterogeneity in the PPV and NPV estimates across different classes of antidepressants (Table 4) with a higher prevalence of the indication. However, there were 2 exceptions to this trend. For fibromyalgia, the baseline probability of this indication was similar for SNRIs and TCAs (3.1% versus 3.4%) but the PPV for SNRIs (62.7%; 95% CI, 47.5%-76.0%) was much higher than for TCAs (32.0%; 95% CI, 16.9%-45.9%). Similarly, the baseline probability of OCD was low for both SSRIs and SNRIs (2.0% versus 0.7%), yet the PPV for SSRIs (81.0%; 95% CI, 62.5%-94.4%) was much higher than for SNRIs (38.1%; 95% CI, 0.0%-77.8%). Unlike the PPV and NPV, the LR estimates were less heterogeneous between different antidepressant classes and did not depend on the prevalence of the indication (see Supporting Information Appendix C).
When prescriptions were stratified by patients' level of chronic comorbidity and age, diagnostic codes for all indications had noticeably poorer sensitivity among patients with at least 1 chronic condition in the Charlson index and patients 65+ years old, especially for depression and anxiety/stress disorders (Tables 5 and 6 ). Although the stratum-specific estimates for sicker and older patients were similar, they were not entirely dependent on each other because these 2 patient characteristics were only weakly positively correlated (Pearson's r = 0.285). Among prescriptions for new versus ongoing antidepressant therapy, the sensitivity and PPV of diagnostic codes was better among prescriptions for new antidepressant therapy for all indications except depression and fibromyalgia (Table 7) .
| Sensitivity analyses
As expected, using a longer lookback window for diagnostic codes increased sensitivity and decreased specificity for all indications, especially pain ( Figure 1A,B) . However, even with a lookback window of −365 days, sensitivity remained low at ≤60% for all indications.
Increasing the length of the lookback window also caused the PPV and LR+ to deteriorate for all indications ( Figure 1C ,E).
Compared with the performance of diagnostic codes from claims data in the past 365 days, diagnostic codes from hospital data in the FIGURE 2 Effect of restricting diagnostic codes to different sources of administrative data. The figure shows the classification parameter estimates for the 7 most common treatment indications based on diagnostic codes recorded within the past 365 days when restricted to diagnostic codes from either hospital discharge data, billings from all physicians, or billings from the prescribing physician only. Abbreviations: PPV, positive predictive value; NPV, negative predictive value; LR+, positive predictive value; LR−, negative predictive value past 365 days had drastically lower sensitivity for all indications (Figure 2A) . However, when diagnostic codes from claims data in the past 365 days were restricted from all physicians to those from the prescriber only, the sensitivity of diagnostic codes was notably lower for pain only (Figure 2A ). Diagnostic codes recorded by the prescriber also had slightly higher (better) PPV and LR+ than diagnostic codes recorded by all physicians ( Figure 2C ,E).
Finally, for all indications except sleeping disorders, the 95% cluster bootstrap-based CIs 28 around the sensitivity and PPV estimates were noticeably wider when they accounted for both within-physician and within-patient clustering than when they accounted for withinpatient clustering only, suggesting that within-physician differences exist in the quality of diagnostic coding for these indications, especially depression (Figure 3 ).
| DISCUSSION
In this study, we estimated the accuracy with which diagnostic codes in Quebec health administrative records reflected indications for antidepressant therapy in primary care. We found that diagnostic codes for a given indication identified only a small proportion of antidepressant prescriptions for the corresponding indication. Moreover, we found that the absence of a diagnostic code for a given indication did not provide much additional value for ruling out the indication.
The findings from this validation study have important implications for epidemiological studies using administrative diagnostic codes Our finding that the sensitivity of pain codes was much lower when restricted to claims from the prescriber compared with claims from all physicians suggests that patients who are prescribed antidepressants for pain are likely to seek treatment from multiple physicians. However, the fact that we did not observe this finding for other indications suggests that primary care physicians may often provide most of the care for these conditions. This study has several limitations. First, although the treatment indications we validated in this study accounted for 99.5% of antidepressant prescriptions in the MOXXI system, we did not validate the indications for the remaining 0.5% of prescriptions (eg, fatigue, bipolar disorder, obesity, Crohn's disease, irritable bowel syndrome, cocaine dependence, and alcoholism) because they were so rare. Second, the external generalizability of our findings depends on the extent to which diagnostic coding practices are similar between MOXXI physicians and physicians in other settings. MOXXI physicians operate within a publicly funded health care system, whereas in other countries like the United States where health care is heavily privatized, physicians have been known to compromise their coding practices for depression due to concerns over obtaining reimbursement or jeopardizing patients' future ability to obtain health insurance. 29 Another limitation of our study is that we could not determine how often MOXXI physicians recorded only one indication for the prescription when there were truly multiple indications. If certain indications were often omitted, then we may have overestimated the NPV and underestimated the PPV of diagnostic codes for these indications.
Finally, in our main analysis, we used a short lookback window of 3 days for diagnostic codes because we knew when the index prescription was written. For researchers using dispensing data where the date of the index visit is unknown, a longer lookback window may be necessary to capture the index visit.
In conclusion, the findings from this study suggest that diagnostic codes from administrative data are poor proxies for antidepressant treatment indications and should not be used alone to infer treatment indications. Future studies should determine whether diagnostic codes can be combined with other information from administrative health databases to improve the ability to predict antidepressant treatment indications.
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